https://www.stellarmr.com/report/Anaplasmosis-Treatment-Market/2063 Anaplasmosis – essentially fever (an acute infectious disease) glycocytic anemia is prevalent in cattle and sometimes human beings. The treatment market for anaplasmosis continues to increase thanks to rising incidences reported in veterinary as well as human medicine. Key treatments comprise of antibiotics including doxycycline as well as supportive therapies used in controlling its symptoms. Increasing awareness, advancement in diagnostics, along with increased research funding are propelling market growth. The reason for the dominance of North America in the market is because of the fact that it has a higher prevalence of diseases and advanced healthcare infrastructure.